Back to Invesco Ltd. Invesco Ltd.

SMMT

19 quarters

Position history for Invesco Ltd.Invesco Ltd.'s holdings in Summit Therapeutics Inc.

Yes. Invesco holds 416,847 shares of SMMT (Summit Therapeutics), worth $6.1M, as of its Q2 2026 13F filing. It reduced the position by 109,256 shares (-20.8%) from Q1 2026. Invesco has held SMMT since Q1 2023, across 14 quarterly 13F filings.

Current Value

$6.1M

Current Shares

416,847

Total Value Change

+$6M

Total Shares Change

+400,708

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
416,847
-20.8%
$6.1M0.0%$14.57
0
2026-Q1
Increased
526,103
+14.1%
$10M0.0%$18.96
32
2025-Q4
Increased
461,301
+8.3%
$8.1M0.0%$17.49
30
2025-Q3
Increased
426,075
+0.5%
$8.8M0.0%$20.66
28
2025-Q2
Increased
424,027
+8.8%
$9M0.0%$21.28
30
2025-Q1
Decreased
389,705
-2.3%
$7.5M0.0%$19.29
0
2024-Q4
Increased
399,050
+435.7%
$7.1M0.0%$17.85
44
2024-Q3
Increased
74,495
+3.9%
$1.6M0.0%$20.89
27
2024-Q2
Decreased
71,677
-5.0%
$559,0810.0%$7.80
0
2024-Q1
Increased
75,477
+7.8%
$312,4750.0%$4.14
25
2023-Q4
Decreased
70,029
-7.4%
$182,7760.0%$2.61
0
2023-Q3
Increased
75,599
+0.7%
$141,3700.0%$1.87
15
2023-Q2
Increased
75,068
+478.2%
$188,4200.0%$2.51
25
2023-Q1
New
12,984
-
$22,7220.0%$1.63
29
2022-Q2
Exited
0
-100.0%
$00.0%$1.00
0
2022-Q1
Increased
11,273
+5.5%
$28,0000.0%$2.45
14
2021-Q4
Decreased
10,689
-44.2%
$28,0000.0%$2.69
0
2021-Q3
Increased
19,167
+18.8%
$96,0000.0%$4.83
17
2021-Q2
New
16,139
-
$120,0000.0%$7.43
34

Other major holders of SMMT: Baker Bros. Advisors LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used